Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ependymoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 485 Leukemia 245 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Lymphoma 132 Myelodysplastic Syndromes 94 Burkitt Lymphoma 76 Lymphoma, Non-Hodgkin 73 Leukemia, Monocytic, Acute 73 Congenital Abnormalities 72 Leukemia, Myelomonocytic, Acute 70 Leukemia, Erythroblastic, Acute 65 Lymphoma, Large B-Cell, Diffuse 64 Leukemia, Megakaryoblastic, Acute 62 Recurrence 58 Lymphoma, Mantle-Cell 57 Lymphoma, Follicular 41 Leukemia, Myelomonocytic, Chronic 39 Hodgkin Disease 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 33 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 28 Blast Crisis 28 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Myeloid, Chronic-Phase 21 Lymphoma, B-Cell, Marginal Zone 20 Multiple Myeloma 19 Leukemia, Eosinophilic, Acute 19

Interventions

Temozolomide 23 Magnetic Resonance Spectroscopy 16 Etoposide 13 Cyclophosphamide 12 Filgrastim 10 Bevacizumab 9 Carboplatin 8 Biopsy 8 Radiotherapy 7 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Cisplatin 6 Thiotepa 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Irinotecan 5 Carmustine 5 sargramostim 4 Vincristine 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Erlotinib Hydrochloride 4 etoposide phosphate 3 Lapatinib 3 Granulocyte Colony-Stimulating Factor 3 Gadolinium DTPA 3 Azacitidine 3 1-methyltryptophan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡